Advertisement

Palpa Cement Industries Limited (PCIL)

Manufacturing · Rs. 633.00 22.00 (+3.60%) as of Sep 24, 2026

Price — last 6 months

Full chart →
Open
605.00
High / Low
638.00 / 605.00
Prev. close
611.00
Volume
1.12 L
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding—
Public holding—

Stock performance

1-week change
+1.43%
1-month change
+5.50%
3-month change
-7.18%
6-month change
—
YTD change
—
1-year change
—
1-month high
656.00
1-month low
576.40
From 52-week high
—
From 52-week low
—
180-day avg price
696.16
360-day avg price
696.16
Avg volume (1w)
51,892
Avg volume (1m)
44,285
Avg volume (6m)
47,608
Avg volume (12m)
47,608
Daily volatility (1m)
2.27%
Beta vs NEPSE (1y)
1.73

Valuation

EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Manufacturing

EPS (Rs.)
N/A
min -6.29avg 452.86max 1,712.27
—
P/E
N/A
min 22.03avg 34.83max 50.04
—
P/B
N/A
min 2.17avg 5.18max 9.28
—
Networth / Share (Rs.)
N/A
min 98.04avg 1,518.08max 5,537.13
—
ROE (%)
N/A
min 0.00avg 10.89max 30.92
—

Technical indicators

RSI (14)53.73Neutral
MACD-3.04Bullish
EMA 5621.82Bullish
EMA 20620.88Bullish
EMA 180——
SMA 50629.78Bullish
SMA 200——
Pivot levels (classic)
S3
579.67
S2
592.33
S1
612.67
PP
625.33
R1
645.67
R2
658.33
R3
678.67

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Manufacturing stocks

PCIL — frequently asked questions

What is Palpa Cement Industries Limited's share price?

Rs. 633.00 as of Sep 24, 2026, the latest NEPSE trading session (+3.60% on the day).

What dividend did PCIL pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.